Back to search

Article

Comparative Evaluation of a 28-Gene versus 70-Gene Panel for Recurrence Risk Prediction in Early-Stage HR-Positive/HER2-Negative Breast Cancer in Chinese Women

2025-07-01

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Multigene expression assays help guide adjuvant therapy decisions in early-stage hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer by predicting recurrence risk. While the 21-gene Oncotype DX and 70-gene MammaPrint tests, developed in Western populations, allow low-risk patients to safely avoid chemotherapy, their validity in Asian cohorts remai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ac280e9e-3fa7-5233-a13a-e35baa919f90
DOI
10.21203/rs.3.rs-6832631/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Evaluation of a 28-Gene versus 70-Gene Panel for Recurrence Risk Prediction in Early-Stage HR-Positive/HER2-Negative Breast Cancer in Chinese WomenDOI 10.21203/rs.3.rs-6832631/v1
Validation of a Clinical-Genomic Model for Patients With Early-Stage Breast Cancer Enrolled in a Taiwanese Multicenter StudySemantic proximity
High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity
Correlation Analysis of 21-Gene Recurrence Score with Gene Pathway Expression and Clinicopathological Features in Hormone Receptor-Positive Early-Stage Breast CancerSemantic proximity
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.Semantic proximity
Prediction of the 70-gene signature (MammaPrint) high versus low risk by nomograms among axillary lymph node positive (LN+) and negative (LN-) Chinese breast cancer patients, a retrospective studySemantic proximity
RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.Semantic proximity
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerSemantic proximity
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.Semantic proximity
A 95-gene Signature Stratifies Recurrence Risk of Invasive Disease in ER-positive, HER2-negative, Node-negative Breast Cancer With Intermediate 21-gene Signature Recurrence ScoresSemantic proximity
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signatureSemantic proximity
Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patientsSemantic proximity
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.